[Intra-tumoral IL-6 down-regulation system as a new therapeutic target to control tumor growth in colorectal carcinoma].
Miki
Chikao
C
Second Department of Surgery, Mie University School of Medicine.
Kusunoki
Masato
M
D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000209:etiology*; D015536:Down-Regulation; D006801:Humans; D018836:Inflammation Mediators / Q000037:antagonists & inhibitors* / Q000502:physiology; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1 / Q000037:antagonists & inhibitors / Q000502:physiology; D015850:Interleukin-6 / Q000502:physiology; D012795:Sialoglycoproteins / Q000494:pharmacology / Q000627:therapeutic use; D000093242:Interleukin-6 Inhibitors
D018836:Inflammation Mediators; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1; D015850:Interleukin-6; D012795:Sialoglycoproteins; D000093242:Interleukin-6 Inhibitors; C507763:IL1RN protein, human